Investor Presentation - pharmacielo.com

1 November 2018 Investor PresentationThispresentation( Presentation )isconfidentialandcontainsproprietarynon -publicinformationregardingPharmaCieloLt d.(the Company , we , us or our ) ,inwholeorinpart, , ,youacknowledgeandagree(i)tomaintainthec onfidentialityofthisdocumentandtheinform ationcontainedherein,(ii)toprotectsuchin formationinthesamemanneryouprotectyourow nconfidentialinformation,whichshallbeatl eastareasonablestandardofcareand(iii) forward-lookingstatements, ,theyarebasedonourcurrentbeliefs,expecta tions,assumptionsandanalysesmadebyusrega rdingthefutureofourbusiness,futureplansa ndstrategies, ,suchas anticipates, or believes, budget, estimates, expects, or isexpected, forecasts, intends, plans, scheduled, orvariationsofsuchwordsandphrasesorstate thatcertainactions,eventsorresults may, might, will, would, could , should, continue, orbetaken, ,amongotherthings,ourfuturefinancialperf ormance,financialcondition,liquidity,lev elsofactivity,thescalabilityofourbusines s,ourprojectedproductioncapacity,thepote ntialsizeofthemarketforcannabisandcannab inoidderivatives,ourcompetitiveadvantage sascomparedtoothergrowingjurisdictions,m arketstrategy,performance,prospects,grow th, ,theseforward-lookingstatementsinvolvekn ownandunknownrisks, ,theserisksincluderisksrelatedtoregulati onofcannabisandcannabinoidderivativesinC anada,Colombiaandotherglobalmarkets.

2 Alackofsignificantrevenueanddependencyon externalfinancingforgrowth,marketdemand, , ,therecanbenoassurancethattheunderlyingo pinions,estimates, ,unlessotherwisestated,theforward-lookin gstatementscontainedinthisreportaremadea softhedateofthisPresentationandwedonotun dertakeanyobligationtoupdatepubliclyorto reviseanyoftheincludedforward-lookingsta tements,whetherasaresultofnewinformation , :ThisPresentationalsocontainsorreference scertainmarket,industryandpeergroupdataw hichisbaseduponinformationfromindependen tindustrypublications,marketresearch, ,suchinformationissubjecttointerpretatio nandcannotbeverifiedwithcompletecertaint yduetolimitsontheavailabilityandreliabil ityofrawdata, , :Totheextentanyforward-lookinginformatio ninthisPresentationconstitutes future-orientedfinancialinformation or financialoutlooks withinthemeaningofapplicableCanadiansecu ritieslaws, ,aswithforward-lookinginformationgeneral ly,are,withoutlimitation, scurrentexpectationsand,asaresult.

3 And Cautionary Note Regarding Forward-Looking Statements1 Municipal Water SupplyArtificial Climate Control SystemHigh Intensity Lighting SystemTypical North American Producer2 Spring Fed WaterNatural Sunlight3It s The Natural Choice3 Fully LicensedTropic of CapricornTropic of Cancer4 Only a few places globally where you can efficientlygrow cannabisEven fewer with the infrastructure & political climate to support it EquatorThe Natural Cannabis BeltVenezuelaColombiaGuyanaEcuadorSurina meFrench GuianaPeruBrazilNatural & consistent 12-hour light cycle and temperate climate creates optimal conditions50%50%Ideal Growing EnvironmentScalableCultivation InfrastructureLow Energy CostsStable Government2ndlargest supplier of Cut Flowers3rdlargest supplier of Coffeelargest supplier of Bananas5thColombiaMedell n5 Experienced Human Capital & Significant, Scalable Cultivation InfrastructureNatural Cost Advantage6 Licensed Producer Aspiration Per GramPer GramVSAnthony Wile, CEO, ,businessstrategist,publisherandauthor, , , , Antunes De Siqueira, COO (Nursery & Propagation Centre)Ahorticulturalentrepreneurwithove r18yearsofexperienceindesigning, , ,focusedonthedevelopment, , sNurseryInc.

4 , Cock-Correa, CEO (Colombia), (Asocolflores)andhasbeenamemberorofficer ofBusinessCorporationofEasternAntioquia( CEO),ColombianFloricultureInnovationCent er(Ceniflores)andtheFloralProductsTradeA ssociation(WFFSA). , , Alberta Escobar, COO (Oil Processing Centre) , ,Colombia sDepartmentofScience, , n, (FormosaPlasticGroup)inCartagena,PlantMa nagerofPol , Laitinen, CFO, DirectorAseniorfinancialservicesexecutiv ewithrecognizedleadership,strategic, , sChoiceFinancial, , svicepresidentofstrategy, (Amex)inadditiontopastroleswithCanadianI mperialBankofCommerce(CIBC) Camilo Alberto Ospina Saldarriaga, Head of Product DevelopmentAmedicaldoctor,publichealthsp ecialistandpassionateentrepreneurwithmor ethan25yearsofexperienceinthedesign,deve lopment,marketingandimplementationofinno vativeprojects,productsandservicesinheal thandsocialsecuritybasedonnewcommunicati onsandinformationtechnologies(ICT). , Management Team7 Non-Executive Board Members8 Simon Langelier, Chairman of the BoardDr.

5 Delon Human, Vice ChairmanHenning von Koss, DirectorMatteo Pellegrini, DirectorDavid Attard, DirectorCarlos Manuel Uribe, DirectorDavid Gordon, Director Licensed by the Colombian Government9 Processing and Extraction Licence Received June 27th, 2016 Step 1: Received October 19th, 2017 Cultivation LicenceStep 2: General permit receivedwith processing licenceExportation PermitStep 3:The only fully licensed producer of medicinal cannabis oil products in Colombia for use in Colombia as well as international exportCompany Owned and Contract Cultivation Facilities10 Nursery & Propagation CentreContract Growers(KG based on ft., 4 growing cycles)Company-OwnedwithIndigenous greenhousesMillion sq. greenhousesMillion sq. greenhousesMillion sq. capacity per yearThousand KG4,900flower capacity per yearThousand KG150flower capacity per yearThousand greenhousesMillion sq. ,530flower capacity per yearThousand KG11 Highly Scalable Business ModelNursery & Propagation Centre Supplies cuttings to support 100+ million sq.

6 Ft. of cultivationContract and Indigenous GrowingSupplies harvested cannabis flower to be processedOil Processing CentreOur Current Capacity vs Fully Funded Canadian ProjectionsSet to meet the global medicinal need for high-quality cannabis oil THOUSANDS OF KGS12 Source: Company Filings, Internal Estimates1201,0002,0003,0004,0005,0006,0 00 Indigenous GrowersNursery & PropagationContract GrowingOwnedOwnedCombined Canadian LPs2020 SupplyOur Nursery and Propagation Centre1314 GMP Oil Processing CentreDistribution Channel Strategy15 Direct DistributionRetail DistributionResearch & Scientific PartnersFinished Goods Manufacturing16 Colombia: First Mover AdvantageCaliMedell nBogotaCartagenaBarranquilla* Based on Colombian government estimatesBucaramangaPastoC cutaPopulation of MillionMedicinal Cannabis Legalized December 2015 Estimated Cannabis Market Size of ~ $2 Billion*Estimated Potential Revenue ~ $600 MillionAmong the Highest Drug Prices in the WorldEstimated PharmaCielo Market Share ~ 30%Colombia: Go to Market Strategy17 UBIQUO: Colombia s onlypatient & e-clinic platform (80,000 patients) Fully owned by PharmaCielo Currently only in Medell n Expected to grow 350,000+ patients over a 36-month period as we roll out to seven new departments (regions) Company-owned-and-operated clinics Large channel pharmacy distribution Non-competitive finished good manufactures Research & scientific partners18 Global Opportunity Potentialby 2032*~$200 BIndustryColombia Can Supply The M Population: M Population.

7 M Primary FocusSecondary Focus*(based on Constellation Brands market estimate)Investment Highlights Efficient, Natural Production Fully Licensed & Operational Scalable Cultivation Facilities Advanced Processing Facilities Strong Management Team1920 Environmental Impact21103,70080 PharmaCieloWarehouse GrowColoradoGreenhouse GrowWashingtonEnvironmental ImpactGlobal Square Meters Requirement / kg1 The full study can be found at:The Huge (or Tiny) Ecological Footprint of equator is the only place to grow without damaging the environment1 A global square meter is a square meter with world average biological productivity. Global Footprint Network, Aug. 16, 2017 Licensed by the Colombian Government22 Legalized in December 2015 by signing of Decree 2467 by President SantosoJuly 2016 Congress approved law 1787,replacing Decree 2467oApril 2017 Approval of Regulatory Decree forLaw 1787 Covers cultivation, extraction and exportation Restricted to cannabis-based extracts for medicinal applications Leading the global decriminalization and medicinal recognition of cannabis Allows the cultivation, processing and extraction of cannabis concentrates from flower that can be sold to Colombian market, used for scientific purposes and for export, enabling the export of derivatives and finished goods globallyLicence Overview Colombia granted PharmaCielo the first Processing and Extraction License on June 27, 2016.

8 This license is a prerequisite to apply for a Cultivation License; no additional Processing and Extraction Licenses will be and Extraction of Cannabis Oil Extracts Licence Colombia granted PharmaCielo the first Cultivation License on October 19, 2017, for the Rionegro facility. License enables the cultivation of cannabis flower for the sole purpose of processing and extraction of cannabis Licence This is not a licensing process. It is a permitting process whereby PharmaCielo needs to verify that the products for export are legal in the country of import. General permit granted with processing Permit